Agenus

About:

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

Website: http://agenusbio.com

Twitter/X: Agenus_Bio

Top Investors: Ligand Pharmaceuticals, Iroquois Capital, Hudson Capital Group, Incyte, Downsview Capital

Description:

Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases. The company's treatment aims to stimulate the immune system to recognize and fight cancer cells. Its goal is to treat cancers with novel combinations utilizing its unique portfolio of checkpoint antibodies, tumor microenvironment modifiers, vaccines, and adjuvants. In addition to a broad portfolio, the company has an accomplished team of scientists, novel technology platforms, and fully-integrated end-to-end capabilities from discovery to GMP manufacturing. It was established in 1994 and is headquartered in Lexington, Massachusetts.